Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

James Galloway

Showing results (11-20 of 206) with videos related to

Pageof 21
Sort By:
Clinical Medicine (London, England)|June 3, 2015
The ying and yang of fever in rheumatic diseaseJames Galloway, Andrew P Cope
Rheumatology (Oxford, England)|July 9, 2018
Better is possibleMark Yates, James Galloway, Marwan Bukhari
Current Rheumatology Reports|September 19, 2018
Differentiating Disease Flare From Infection: A Common Problem in Rheumatology. Do 18F-FDG PET/CT Scans and Novel Biomarkers Hold The Answer?Elizabeth Mabey, Andrew Rutherford, James Galloway
Eye (London, England)|June 14, 2019
Cochrane corner: why we still don't know whether anti-TNF biologic therapies impact uveitic macular oedemaTasanee Braithwaite, Nicki Davis, James Galloway
Rheumatology (Oxford, England)|January 6, 2026
Aligning monitoring with risk: what the new British Society for Rheumatology guidance means for practiceLouise Mercer, Katie Bechman, James Galloway
Rheumatology (Oxford, England)|December 14, 2019
The use of real-world data to address questions of patient safetyMark Yates, Katie Bechman, James Galloway
Rheumatology (Oxford, England)|December 12, 2018
Mobile apps, wearables and the future of technology in rheumatic disease careFaith Matcham, Matthew Hotopf, James Galloway
Autoimmunity Reviews|October 30, 2020
Overview of IgG4-related aortitis and periaortitis. A decade since their first descriptionElena Nikiphorou, James Galloway, George E Fragoulis
The Journal of Rheumatology|April 15, 2024
Patient-Initiated Follow-UpEdward Alveyn, James Galloway, Laura C Coates
Rheumatology (Oxford, England)|August 8, 2018
The price of good health careMark D Russell, Marwan Bukhari, James Galloway
Pageof 21

Showing results (11-20 of 206) with videos related to

Sort By:
Pageof 21
Clinical Medicine (London, England)|June 3, 2015
The ying and yang of fever in rheumatic diseaseJames Galloway, Andrew P Cope
Rheumatology (Oxford, England)|July 9, 2018
Better is possibleMark Yates, James Galloway, Marwan Bukhari
Current Rheumatology Reports|September 19, 2018
Differentiating Disease Flare From Infection: A Common Problem in Rheumatology. Do 18F-FDG PET/CT Scans and Novel Biomarkers Hold The Answer?Elizabeth Mabey, Andrew Rutherford, James Galloway
Eye (London, England)|June 14, 2019
Cochrane corner: why we still don't know whether anti-TNF biologic therapies impact uveitic macular oedemaTasanee Braithwaite, Nicki Davis, James Galloway
Rheumatology (Oxford, England)|January 6, 2026
Aligning monitoring with risk: what the new British Society for Rheumatology guidance means for practiceLouise Mercer, Katie Bechman, James Galloway
Rheumatology (Oxford, England)|December 14, 2019
The use of real-world data to address questions of patient safetyMark Yates, Katie Bechman, James Galloway
Rheumatology (Oxford, England)|December 12, 2018
Mobile apps, wearables and the future of technology in rheumatic disease careFaith Matcham, Matthew Hotopf, James Galloway
Autoimmunity Reviews|October 30, 2020
Overview of IgG4-related aortitis and periaortitis. A decade since their first descriptionElena Nikiphorou, James Galloway, George E Fragoulis
The Journal of Rheumatology|April 15, 2024
Patient-Initiated Follow-UpEdward Alveyn, James Galloway, Laura C Coates
Rheumatology (Oxford, England)|August 8, 2018
The price of good health careMark D Russell, Marwan Bukhari, James Galloway
Pageof 21